Bilateral visual improvement with unilateral gene therapy injection for Leber hereditary optic neuropathy

Journal: Science Translational Medicine

Published: 2020-12-09

DOI: 10.1126/scitranslmed.aaz7423

Affiliations: 24

Authors: 23

Go to article
Institutions Share
Gensight Biologics, USA, United States of America (USA) 0.17
GenSight Biologics, France 0.17
Woodruff Health Sciences Center (WHSC), Emory University, United States of America (USA) 0.09
Wills Eye Hospital, United States of America (USA) 0.09
University Hospital of Munich (KUM), LMU, Germany 0.06
Vision Institute, France 0.05
Vanderbilt University Medical Center (VUMC), United States of America (USA) 0.04
IRCCS Istituto delle Scienze Neurologiche di Bologna (ISNB), Italy 0.04
University of Bologna (UNIBO), Italy 0.04
Doheny Eye Institute (DEI), United States of America (USA) 0.04
UCLA Health, United States of America (USA) 0.04
Rothschild Foundation Hospital, France 0.03
Centres d'Investigations Cliniques (CIC) 1423, France 0.03
The Ottawa Hospital (TOH), Canada 0.01
German Center for Neurodegenerative Diseases within the Helmholtz Association (DZNE), Germany 0.01
Cluster of Excellence - Munich Cluster for Systems Neurology (SyNergy), LMU, Germany 0.01
Health Sciences, Pitt, United States of America (USA) 0.01
MRC Mitochondrial Biology Unit (MBU), University of Cambridge, United Kingdom (UK) 0.01
UCL, United Kingdom (UK) 0.01
Moorfields Eye Hospital, Moorfields Eye Hospital NHS Foundation Trust, United Kingdom (UK) 0.01
Addenbrooke's Hospital, United Kingdom (UK) 0.01
University of Cambridge, United Kingdom (UK) 0.01

Return